Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ADMA Biologics Inc (ADMA) vs Novavax Inc (NVAX) Price & Performance

ADMA Biologics IncTrade
Novavax IncTrade

Price performance (Past 24H)

Key statistics

ADMA Biologics Inc vs Novavax Inc — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Novavax Inc trades at $7.96 (market cap $1.31B). The key difference: ADMA Biologics Inc is the larger of the two by market cap, and Novavax Inc is trading nearer its 52-week high, ADMA Biologics Inc nearer its low. Which is the better fit depends on your goals.

ADMANVAX
Market Cap
$2.22B$1.31B
Sector
HealthHealth
52-Week High
$20.38$11.19
52-Week Low
$7.60$6.22
Enterprise Value
$2.29B$889.30M

Returns comparison

Trailing returns across standard periods

About ADMA Biologics Inc

ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.

Read more on ADMA

About Novavax Inc

Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.

Read more on NVAX